Conversion Ratio between Botox®, Dysport®, and Xeomin® in Clinical Practice

Author: Scaglione Francesco  

Publisher: MDPI

E-ISSN: 2072-6651|8|3|65-65

ISSN: 2072-6651

Source: Toxins, Vol.8, Iss.3, 2016-03, pp. : 65-65

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content